/Companies

Atomo Diagnostics

3 known investors

Find your way into Atomo Diagnostics

Sign up to see every warm intro you have to Atomo Diagnostics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Atomo Diagnostics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Atomo Diagnostics develops diagnostic ecosystems and mobile applications for point-of-care testing, including whole-blood cassettes and reader devices compatible with smartphones for remote diagnostics. The company serves clinicians and self-test users in the in-vitro diagnostics and digital health markets.

Founders & leadership

JKJohn Kelly
John KellyFounder and CEOJohn Kelly has held product development roles at ResMed and other medical device companies. He is founder and CEO of Atomo Diagnostics, which develops point-of-care diagnostic devices and mobile applications for remote testing.

Investors · 3

Funding

SEC filings, press & company announcements
  • Undisclosed amountShare Purchase PlanMay 2026
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Atomo Diagnostics do?
Atomo Diagnostics develops diagnostic ecosystems and mobile applications for point-of-care testing, including whole-blood cassettes and reader devices compatible with smartphones for remote diagnostics. The company serves clinicians and self-test users in the in-vitro diagnostics and digital health markets.
Who founded Atomo Diagnostics?
Atomo Diagnostics was founded by John Kelly.
Who are Atomo Diagnostics's investors?
Atomo Diagnostics's investors include Global Health Investment Corporation, Sydney Angels, Transition Level Investments.